Latest Share Chat

Imperial Innovations Group Share News (IVO)

Imperial Innovations Group Information

There is currently no data for IVO

Thursday tips round-up: Imperial Innovations, Vertu Motors

Thu, 17th Oct 2013 07:07

Imperial Innovations has the right to take interesting discoveries from Imperial College London and package them up into companies that eventually can be floated or sold. The majority of its 92 investments are in pharmaceuticals; one of the most promising, Circassia, is well into clinical trials for treatments for cat, dust mite and grass allergies. Imperial's full-year figures revealed that the value of the portfolio of investments grew by 21 per cent to 188?m pounds. Add on cash and other assets and total net assets were 230.5m pounds. That compares with a market capitalisation of £384?m and means that there is a lot of hope value built into the shares, which were up 25p to 385p on Wednesday. Yet the company does say that a "number" ? let's say a handful?? of its investments are heading for "value-creation events", a sale to Big Pharma or an initial public offering (IPO). Circassia is in the books at £225m in all, so it is big enough, although it probably won't be the first. The shares are tightly held, almost a half with Invesco. This is one to buy as a high-risk investment, if they become available, and tuck away for a time, although only with money you can afford to leave untouched, The Times' Tempus column says. Wednesday's halfway figures from Vertu Motors showed that its strategy to buy under-performing car dealerships in a still-fragmented industry and buff them is working. Adjusted pre-tax profits went ahead by 80% to £8.8m while the dividend was up by 20% to 0.3p. That came on the back of strong domestic demand ? industry figures suggest that car sales will rise almost 20% this year ? and has been driven by the dumping in the UK of large numbers of vehicles made in Europe and surplus to demand there, with attractive finance packages. Somewhat ironically, the only downside risk for the company is a recovery in the Eurozone, should that lead to said surplus in vehicles disappearing. Also worth pointing out, the firm raised £50m in June to pay for Farnell Land Rover, which took it into the premium car arena, and for other acquisitions. The shares sell on 14 times holdings. About right, then. 'Hold', says Tempus.Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.AB

More News

2 Jun 2014 09:13

Imperial Innovation Looks To Raise GBP150.0 Million In Share Placing

LONDON (Alliance News) - Imperial Innovations Group PLC Monday detailed plans to raise up to GBP150.0 million before expenses through a share placing with new and existing investors, as it looks to support its existing portfolio companies, source opportunities to invest in new technologies, and f

30 May 2014 07:50

Imperial Innovations 44% Owned Veryan Reports Positive Data

LONDON (Alliance News) - Imperial Innovations Group PLC Friday said the third-largest company in its portfolio is set to publish positive new data after a controlled study. In a statement, Imperial Innovations said that Veryan Medical will Friday publish the full two-year data from the Mimi

22 May 2014 13:08

Imperial Innovations Says JustYoyo Has Completed Investment Round

LONDON (Alliance News) - Imperial Innovations Group PLC Thursday said its portfolio company JustYoyo has completed a GBP2.8 million seed investment round. The investment round for the mobile payments and loyalty company was completing with a second tranche investment, with the first investm

24 Apr 2014 13:58

Imperial Innovations' Nexeon completes manufacturing facility

Imperial Innovations, the AIM-listed technology group, said that its portfolio company Nexeon has completed the construction and commissioning of its manufacturing facility at its headquarters in Oxfordshire. Nexeon is Imperial's second-largest portfolio company and develops silicon anode techno

24 Apr 2014 11:15

Imperial Innovations Says Nexeon Completes Construction Of Headquarters

LONDON (Alliance News) - Imperial Innovations PLC said Thursday its portfolio company Nexeon Ltd has completed the construction and commissioning of its process development and manufacturing facility at its headquarters in Oxfordshire. Nexeon is Innovations' second largest portfolio company

3 Apr 2014 15:17

DIRECTOR DEALINGS: Imperial Innovations Non-Executive Buys Shares

LONDON (Alliance News) - Imperial Innovations Group PLC Thursday said Non-Executive director David Begg bought 1,470 shares at a price of 403 pence per share. Following this transaction, Begg now holds 21,319 shares, which represents 0.02% stake in the firm. Shares in the software com

28 Mar 2014 13:14

Imperial Innovations Profit Jumps As Circassia Investment Pays Off

LONDON (Alliance News) - Imperial Innovations Group PLC Friday saw pretax profit rise in the half-year ended January 31, 2014, boosted by the success of its largest investment, Circassia Pharmaceuticals PLC. The technology investment company posted a pretax profit of GBP24.4 million, up fro

13 Mar 2014 14:22

CORRECTED-UPDATE 2-Allergy drug firm Circassia prices London listing at top of range

(Corrects Reuters Instrument Code to in first paragraph) By Freya Berry LONDON, March 13 (Reuters) - British allergy drug development firm Circassia priced its initial public share offer at the top of its range on Thursday, in the biggest London market debut in years for a biotech com

13 Mar 2014 08:41

Imperial Innovations' Circassia Prices IPO

LONDON (Alliance News) - Imperial Innovations Group PLC Thursday said its largest portfolio company, Circassia Pharmaceuticals, has successfully priced its IPO on the London Stock Exchange's Main Market. Circassia is expected to raise gross proceeds of about GBP200 million pounds in the pla

6 Feb 2014 13:55

Imperial Innovations' Circassia to list on LSE main market

Clinical-stage specialty biopharmaceutical company Circassia has announced its intention to float on the London Stock Exchange's Main Market. The company is focused on the development and commercialisation of a range of immunotherapy products for the treatment of allergies, such as those to cats, g

6 Feb 2014 08:32

UK MORNING BRIEFING: Vodafone Gains, AstraZeneca Falls At Open

LONDON (Alliance News) - Vodafone has delivered results in line with expectations Thursday morning, helping to give UK share a positive start. Vodafone is up 1.4%.

Meanwhile, AstraZeneca has opened down 2.1% after reporting lower revenue and profit

6 Feb 2014 08:31

UPDATE 1-Circassia seeks $285 mln in bumper UK biotech IPO

* Allergy firm tests European market for larger biotech IPOs * Follows boom in biotech offerings in United States * Funds to help bring cat allergy vaccine to market By Paul Sandle LONDON, Feb 6 (Reuters) - Circassia, a company developing allergy treatments based on a disc

6 Feb 2014 08:31

UK MORNING BRIEFING:

6 Feb 2014 00:01

Allergy drug firm Circassia seeks $285 mln in London IPO

LONDON, Feb 6 (Reuters) - Circassia, a company developing allergy treatments based on a discovery by scientists at Imperial College in London, plans to raise about 175 million pounds ($285 million) of new funds in a stock market debut to bring its cat allergy vaccine to market. Chief execut

7 Jan 2014 08:22

Latest Share Chat

Imperial Innovations Group Share News (IVO)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday tips round-up: Imperial Innovations, Vertu Motors

Login to your account

Quickpicks are a member only feature

Login to your account